Cancer Prevention News and Research

RSS

Rice University neurobiologist wins NIH grant to study enteric nervous system development

Rice University neurobiologist Rosa Uribe will be hitting the books for her latest study of the digestive system, but some of the pages in her books are a billion years old.

10 May 2021

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Recently published research from the University of Arizona Health Sciences shows that advanced-stage kidney cancer is more common in Hispanic Americans and Native Americans than in non-Hispanic whites, and that both Hispanic Americans and Native Americans in Arizona have an increased risk of mortality from the disease.

6 May 2021

Cancer researchers receive $3 million NCI grant to study cognitive dysfunction after chemotherapy

Cancer researchers at the University of Pittsburgh School of Medicine and Indiana University received a five-year, $3 million grant from the National Cancer Institute (NCI) to study cognitive dysfunction after chemotherapy.

4 May 2021

New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy

UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients.

3 May 2021

Researchers address the importance of increasing efforts to limit indoor tanning among minors

There is substantial evidence that indoor tanning is associated with increased risk of skin cancer – the most common type of cancer nationwide according to the American Cancer Society. Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning.

29 Apr 2021

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

With COVID-19 vaccines more readily available than ever, there remains vaccine hesitancy in diverse communities across metropolitan Houston and beyond.

28 Apr 2021

Researchers identify potential therapeutic target to prevent neurodegeneration after a stroke

Researchers with the Peter O'Donnell Jr. Brain Institute at UT Southwestern have identified a new protein implicated in cell death that provides a potential therapeutic target that could prevent or delay the progress of neurodegenerative diseases following a stroke.

27 Apr 2021

U-M study finds low HPV vaccination rate among young adult men in the U.S.

The COVID-19 vaccine isn't having any trouble attracting suitors. But there's another, older model that's been mostly ignored by the young men of America: the HPV vaccine.

27 Apr 2021

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense's Peer Reviewed Cancer Research Program.

27 Apr 2021

Cognitive outcomes in survivors of childhood cancers have been largely understudied

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income.

23 Apr 2021

Study: Women at high risk of breast cancer face financial barriers to care

Women at high risk of breast cancer face cost-associated barriers to care even when they have health insurance, a new study has found.

21 Apr 2021

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).

19 Apr 2021

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.

19 Apr 2021

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Stand Up To Cancer and Mirati Therapeutics Inc. - a late-stage targeted oncology company - today announced that Mirati will contribute a $4 million grant to SU2C to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst program.

19 Apr 2021

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).

15 Apr 2021

Commonly used drug for neuromuscular diseases could also help prevent certain skin cancers

New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.

13 Apr 2021

New technology shows encouraging results for treating osteosarcoma

A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.

13 Apr 2021

Cancer Prevention News and Research

Rice University neurobiologist wins NIH grant to study enteric nervous system development

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Cancer researchers receive $3 million NCI grant to study cognitive dysfunction after chemotherapy

New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy

Researchers address the importance of increasing efforts to limit indoor tanning among minors

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

Researchers identify potential therapeutic target to prevent neurodegeneration after a stroke

U-M study finds low HPV vaccination rate among young adult men in the U.S.

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Cognitive outcomes in survivors of childhood cancers have been largely understudied

Study: Women at high risk of breast cancer face financial barriers to care

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

Commonly used drug for neuromuscular diseases could also help prevent certain skin cancers

New technology shows encouraging results for treating osteosarcoma

Young early-onset colorectal cancer patients have a better survival rate, study shows

Yale researchers provide new insights into acquired resistance to cancer immunotherapy

Novel immunotherapy approach may offer therapeutic advantages for melanoma

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News